BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 18716559)

  • 1. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes.
    Utter S; Tamboli IY; Walter J; Upadhaya AR; Birkenmeier G; Pietrzik CU; Ghebremedhin E; Thal DR
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
    Thal DR; Larionov S; Abramowski D; Wiederhold KH; Van Dooren T; Yamaguchi H; Haass C; Van Leuven F; Staufenbiel M; Capetillo-Zarate E
    Neurobiol Aging; 2007 Aug; 28(8):1221-30. PubMed ID: 16815595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death.
    Bruinsma IB; Wilhelmus MM; Kox M; Veerhuis R; de Waal RM; Verbeek MM
    Brain Res; 2010 Feb; 1315():169-80. PubMed ID: 20034483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
    Donahue JE; Johanson CE
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
    Attems J; Jellinger KA; Lintner F
    Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.
    Nicoll JA; Yamada M; Frackowiak J; Mazur-Kolecka B; Weller RO
    Neurobiol Aging; 2004; 25(5):589-97; discussion 603-4. PubMed ID: 15172734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
    van Helmond ZK; Miners JS; Bednall E; Chalmers KA; Zhang Y; Wilcock GK; Love S; Kehoe PG
    Neuropathol Appl Neurobiol; 2007 Jun; 33(3):317-27. PubMed ID: 17493012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible role of scavenger receptor SRCL in the clearance of amyloid-beta in Alzheimer's disease.
    Nakamura K; Ohya W; Funakoshi H; Sakaguchi G; Kato A; Takeda M; Kudo T; Nakamura T
    J Neurosci Res; 2006 Sep; 84(4):874-90. PubMed ID: 16868960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
    Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
    Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy.
    Christoforidis M; Schober R; Krohn K
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):11-9. PubMed ID: 15634227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
    Miners JS; Van Helmond Z; Chalmers K; Wilcock G; Love S; Kehoe PG
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):1012-21. PubMed ID: 17021406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE, vascular pathology, and the AD brain.
    Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
    Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy.
    Miners JS; Ashby E; Van Helmond Z; Chalmers KA; Palmer LE; Love S; Kehoe PG
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):181-93. PubMed ID: 17973905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype.
    Trembath D; Ervin JF; Broom L; Szymanski M; Welsh-Bohmer K; Pieper C; Hulette CM
    Acta Neuropathol; 2007 Jan; 113(1):23-31. PubMed ID: 17089130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
    Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
    Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
    Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
    Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides.
    Koistinaho M; Lin S; Wu X; Esterman M; Koger D; Hanson J; Higgs R; Liu F; Malkani S; Bales KR; Paul SM
    Nat Med; 2004 Jul; 10(7):719-26. PubMed ID: 15195085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
    Williams S; Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.